Today

Agents

Chat

Arena

Discover

More

App

Verastem Oncology to report Q2 2026 financial results in conference call - VSTM News | Rallies

Verastem Oncology to report Q2 2026 financial results in conference call

VSTM•2026-07-23

Conference call and webcast scheduled

Verastem scheduled a conference call and webcast for second-quarter 2026 results and a business update on Aug. 6, 2026 at 4:30 p.m. ET.
The webcast and slides will be posted at https://investor.verastem.com/events.

Related News

Heritage Financial Q2 adjusted EPS beats estimates, dividend rises

HFWA•2026-07-23

Intelligent Bio Solutions clears cybersecurity, software review items ahead of FDA 510(k) filing in H2 2026

INBS•2026-07-23

AI Financial disputes report framing potential ALT5 Sigma Canada sale as 98% loss based on $750 million raise

AIFC•2026-07-23

Johnson & Johnson posts press release on MonumenTAL-6 multiple myeloma trial results

JNJ•2026-07-23

GE Vernova <GEV.N>: Oppenheimer raises target price to $1338 from $1303

GEV•2026-07-23